Business context and reporting period
Filing identity: The provided filing is Spherix Incorporated’s Form 10-K for the fiscal year ended December 31, 2016, filed March 31, 2017. This does not match the request metadata naming Dominari Holdings Inc. or “2016 Q4”; verify that this is the intended filing. Figures below are for Spherix and its consolidated subsidiaries.
Spherix is an intellectual-property company focused on licensing and monetizing patent portfolios, principally in wireless communications and telecommunications. It reported minimal revenue and relied on licensing, settlements and patent litigation; it had five full-time employees at year-end.
Financial performance and position
| Metric | 2016 | 2015 |
|---|---|---|
| Revenue | $0.877 million | $0.033 million |
| Operating loss | $8.551 million | $52.010 million |
| Net loss | $6.476 million | $51.465 million |
| Income (loss) attributable to common stockholders | $25.004 million | ($42.303 million) |
| Cash flow from operations | $0.070 million | ($4.620 million) |
2016 common-stockholder income was not evidence of operating profitability: it included a $31.480 million noncash deemed capital contribution from cancellation of Series H preferred stock. Revenue primarily reflected amortization of deferred revenue from RPX license agreements. Operating margin was deeply negative; a revenue margin comparison is not meaningful given the small revenue base and substantial impairment and amortization charges.
At December 31, 2016, total assets were $11.277 million, including $0.134 million cash and cash equivalents and $6.025 million marketable securities. Current assets were $6.294 million and current liabilities $2.670 million, for working capital of approximately $3.6 million. Total liabilities were $5.959 million; the balance sheet reports warrant and lease liabilities and deferred revenue, but no conventional borrowings are identified in the provided text. Stockholders’ equity was $5.318 million; accumulated deficit was $141.749 million.
Investing activities used $2.974 million, chiefly reflecting purchases of marketable securities net of sales; financing activities provided $2.896 million, including $2.140 million net proceeds from a common-stock offering and $0.760 million from warrant exercises. Cash and cash equivalents declined $0.008 million.
Material changes versus 2015
- Revenue rose to $0.877 million from $0.033 million, mainly from recognition of RPX-related deferred revenue.
- Operating loss narrowed by $43.459 million, primarily because impairment charges fell to $2.713 million from $40.600 million and patent amortization declined to $2.135 million from $6.317 million. Compensation expense increased by $0.226 million.
- Net loss narrowed substantially, while common-stockholder results swung to income because of the noncash preferred-stock extinguishment contribution.
- Cash from operations improved to $0.070 million from cash used of $4.620 million; the 2016 figure benefited from $3.497 million of deferred-revenue changes and significant noncash expenses.
- Marketable securities increased to $6.025 million from $3.392 million. The company issued 1,592,357 shares in an August 2016 offering at $1.57 per share, netting $2.1 million.
Outlook, risks, contingencies and unusual items
- Liquidity: Management stated that funds were sufficient for at least the next 12 months, but also said existing liquidity was insufficient for foreseeable operating, working-capital and other financing needs. Additional debt or equity financing may be necessary and may not be available on acceptable terms. The company reported it was ineligible at year-end to sell securities under its effective Form S-3 shelf under the applicable one-third limitation.
- Monetization plan: Under its 2016 agreement with Equitable IP Corporation, the parties share net monetization revenue equally. Equitable is responsible for specified patent-maintenance and prosecution costs; about 186 of more than 330 patent assets had been assigned for monetization. Further assignment was conditional on meeting agreement terms by December 2017. Management gave no quantified revenue or earnings guidance.
- Litigation: Equitable’s affiliate had filed multiple patent-infringement cases. Spherix settled with Uniden in January 2017 and licensed the asserted patents; the appeal concerning invalidity findings against one patent continued. Several other cases remained pending, including motions to dismiss. Patent validity, infringement findings, timing, legal costs and recoveries are uncertain.
- Patent-related obligations: Rockstar may receive contingent participation in certain future recoveries, including a potential $13 million payment after specified recovery thresholds, plus participation percentages. These obligations could affect liquidity if recoveries occur.
- Asset impairment: Spherix recorded $2.713 million of 2016 patent-asset impairment after a $38.9 million impairment in 2015. Net patent portfolios and rights were $4.951 million at year-end; further impairments were identified as a risk.
- Controls: Management concluded disclosure controls and internal control over financial reporting were not effective at December 31, 2016, citing inadequate segregation of duties and inadequate controls to ensure material transactions and developments were reflected. Management described remediation efforts, subject to limited financial and human resources. The auditor gave an unqualified opinion on the financial statements but did not audit internal-control effectiveness.
- Other risks: The company cited continuing losses, dependence on patent enforcement, potential patent invalidation, litigation expense, competition, limited access to capital, volatile and thinly traded shares, and Nasdaq listing compliance. Shares had fallen to a 2016 fourth-quarter low of $0.87; the company had regained Nasdaq bid-price compliance after a 1-for-19 reverse split.
- Accounting and unusual items: A $2.257 million noncash gain from the change in fair value of warrant liabilities reduced the reported loss. The full $39.180 million deferred-tax asset was offset by a valuation allowance; no income-tax provision was reported.
Most important facts for investors to verify
- Confirm the issuer and period: the supplied document is Spherix’s 2016 annual report, not a Dominari Holdings filing or a standalone Q4 report.
- Review the audited financial statements and RPX accounting: the $25.004 million common-stockholder income chiefly reflects a $31.480 million noncash preferred-stock cancellation contribution, while the company had a $6.476 million net loss.
- Assess actual liquidity and financing runway against the differing management statements about funding for the next 12 months and insufficient foreseeable liquidity; verify cash, marketable securities, restrictions and subsequent financing.
- Check current outcomes of Equitable’s pending cases, the Uniden appeal, patent validity and any resulting cash recoveries or legal obligations.
- Monitor internal-control remediation, subsequent impairment indicators, Nasdaq listing status, dilution from warrants and equity plans, and contingent payments to Rockstar.